Bio-gen Extracts, a pioneer in the development and manufacturing of nutraceutical ingredients, proudly announces a significant milestone in its commitment to promoting healthier living. The company has successfully obtained a US Patent for its ground-breaking product, FenuLean®, which is derived from fenugreek seeds (Trigonella foenum-graceum), containing soluble fibre, insoluble fibre, resistant starch and protein. This patent not only validates the exceptional composition of FenuLean® but also recognizes its holistic health benefits.
FenuLean® is a versatile ingredient that serves as the cornerstone for the development of functional foods, personalised dietary plans, and nutritional supplements. It signifies a transformative shift in our approach to health and wellness.
In the face of the global rise in obesity, a critical risk factor for type 2 diabetes, there is an urgent need for novel, natural, and effective solutions. FenuLean®, with its enhanced organoleptic properties, effectively addresses this need. A randomised, double-blind, multicentre study suggests that FenuLean® promotes feelings of satiety, leading to appetite suppression and a reduced desire to consume food. This contributes significantly to weight management.
Its potential goes beyond this, addressing various conditions, including glucose homeostasis and the management of serum insulin levels. This revolutionary product opens new avenues in the pursuit of healthier living, providing individuals with a natural and effective means to improve metabolic health and overall well-being.
The granted patent underscores Bio-gen Extracts' unwavering dedication to innovating the dietary landscape and offering an alternative approach to weight and blood sugar management. Bio-gen Extracts continues to lead the industry with its cutting-edge solutions, empowering people to "Choose Good Health™" and make healthier choices for a better tomorrow.
For inquiries or further information, please contact: email@example.com